Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KYMR
#1075
Kymera Therapeutics, Inc. Common Stock
89.891
0
USD
+1.54%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.54%
Monthly Change
+11.71%
6 month change
+52.10%
Year Change
+52.10%
Previous Close
88.530
0
Open
89.865
0
Bid
Ask
Low
89.865
0
High
89.891
0
Volume
78
Markets
US Stock Market
Healthcare
KYMR
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
44.81 M
51.7 M
55.18 M
61.11 M
64.94 M
81.64 M
—
Valuation ratios
Enterprise value
2.75 B
3.23 B
1.3 B
1.44 B
2.49 B
6 B
14.43 B
Price to earnings ratio
—
—
-8.66
-10.06
-13.5
-21.09
-58.15
Price to sales ratio
—
—
28.61
18.83
64.14
167.66
383.27
Price to cash flow ratio
—
—
-8.75
-14.39
-15.52
-28.23
-70.51
Price to book ratio
—
—
2.73
3.75
3.61
4.16
7.08
Enterprise value to EBITDA ratio
-61.68
-32.96
-8.23
-8.89
-8.27
-15.77
-40.26
Profitability ratios
Return on assets %
-0.09
-0.17
-0.26
-0.26
-0.23
-0.18
-0.26
Return on equity %
-0.16
-0.22
-0.32
-0.37
-0.27
-0.2
-0.3
Return on invested capital %
-65.97
-160.54
-290.93
—
—
-199.2
—
Gross margin %
100
100
100
100
0
0
0
Operating margin %
-136.05
-138.03
-344.37
-210.62
-555.82
-891.07
-7 830.73
EBITDA margin %
-130.87
-134.74
-338.02
-206.08
-640.16
-969.87
-8 054.78
Net margin %
-133.96
-137.6
-330.6
-186.99
-475.57
-794.04
-6 967.04
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
2.73
4.88
5.88
4.73
7.53
10.47
34.66
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.07
0.13
0.08
0.13
0.06
0.03
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-2.84
-1.76
-2.59
-2.76
-2.83
EBIT per share
—
—
-2.99
-2.84
-4.11
-4.6
-4.68
EBITDA per share
—
—
-2.93
-2.78
-4.02
-4.5
-4.58
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
7.55
6.42
6.51
10.04
29.88
Net current asset value per share
—
—
7.78
6.94
6.8
10.31
31.67
Tangible book value per share
—
—
9.09
6.77
11.14
18.7
51.42
Working capital per share
—
—
6.45
5.48
5.9
9.33
28.04
Book value per share
—
—
9.09
6.77
11.14
18.7
51.42
News
KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug
KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
Kymera at Leerink Global Healthcare: Strategic Insights on Drug Development
Kymera to present atopic dermatitis trial data at AAD meeting
Kymera at TD Cowen Conference: Strategic Insights on Drug Programs
Stephens raises Kymera Therapeutics price target to $100 on pipeline
Kymera Q4 Loss Wider Than Expected, Cash Boost Extends Runway
Morgan Stanley cuts Kymera Therapeutics stock price target on pipeline progress
RBC Capital raises Kymera Therapeutics price target on pipeline progress
RBC Capital raises Kymera Therapeutics price target on pipeline
Stifel reiterates Buy rating on Kymera Therapeutics stock at $114